Culig Z - Search Results

1

KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.

Limberger T, Schlederer M, Trachtová K, Garces de Los Fayos Alonso I, Yang J, Högler S, Sternberg C, Bystry V, Oppelt J, Tichý B, Schmeidl M, Kodajova P, Jäger A, Neubauer HA, Oberhuber M, Schmalzbauer BS, Pospisilova S, Dolznig H, Wadsak W, Culig Z, Turner SD, Egger G, Lagger S, Kenner L. Limberger T, et al. Among authors: culig z. Mol Cancer. 2022 Mar 30;21(1):89. doi: 10.1186/s12943-022-01542-8. Mol Cancer. 2022. PMID: 35354467 Free PMC article.

2

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

Culig Z, Hobisch A, Herold M, Hittmair A, Thurnher M, Eder IE, Cronauer MV, Rieser C, Ramoner R, Bartsch G, Klocker H, Konwalinka G. Culig Z, et al. Br J Cancer. 1998 Oct;78(8):1004-11. doi: 10.1038/bjc.1998.619. Br J Cancer. 1998. PMID: 9792142 Free PMC article.

3

Androgen receptors in prostate cancer.

Culig Z, Klocker H, Bartsch G, Hobisch A. Culig Z, et al. Endocr Relat Cancer. 2002 Sep;9(3):155-70. doi: 10.1677/erc.0.0090155. Endocr Relat Cancer. 2002. PMID: 12237244 Review.

4

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.

Neuwirt H, Puhr M, Santer FR, Susani M, Doppler W, Marcias G, Rauch V, Brugger M, Hobisch A, Kenner L, Culig Z. Neuwirt H, et al. Among authors: culig z. Am J Pathol. 2009 May;174(5):1921-30. doi: 10.2353/ajpath.2009.080751. Epub 2009 Mar 26. Am J Pathol. 2009. PMID: 19342366 Free PMC article.

5

Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.

Malinowska K, Cavarretta IT, Susani M, Wrulich OA, Uberall F, Kenner L, Culig Z. Malinowska K, et al. Among authors: culig z. Prostate. 2009 Jul 1;69(10):1109-18. doi: 10.1002/pros.20956. Prostate. 2009. PMID: 19353593

6

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways.

Puhr M, Santer FR, Neuwirt H, Susani M, Nemeth JA, Hobisch A, Kenner L, Culig Z. Puhr M, et al. Among authors: culig z. Cancer Res. 2009 Sep 15;69(18):7375-84. doi: 10.1158/0008-5472.CAN-09-0806. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738059

7

[Diagnostic of prostate cancer: conventional and molecular or cell biological methods].

Susani M, Kenner L, Culig Z. Susani M, et al. Among authors: culig z. Pathologe. 2009 Dec;30 Suppl 2:154-7. doi: 10.1007/s00292-009-1213-5. Pathologe. 2009. PMID: 19802609 Review. German.

8

Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.

Culig Z, Puhr M. Culig Z, et al. Mol Cell Endocrinol. 2012 Sep 5;360(1-2):52-8. doi: 10.1016/j.mce.2011.05.033. Epub 2011 Jun 1. Mol Cell Endocrinol. 2012. PMID: 21664423 Free PMC article. Review.

9

Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines.

Santer FR, Höschele PP, Oh SJ, Erb HH, Bouchal J, Cavarretta IT, Parson W, Meyers DJ, Cole PA, Culig Z. Santer FR, et al. Among authors: culig z. Mol Cancer Ther. 2011 Sep;10(9):1644-55. doi: 10.1158/1535-7163.MCT-11-0182. Epub 2011 Jun 27. Mol Cancer Ther. 2011. PMID: 21709130

10

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.

Oh SJ, Erb HH, Hobisch A, Santer FR, Culig Z. Oh SJ, et al. Among authors: culig z. Endocr Relat Cancer. 2012 May 3;19(3):305-19. doi: 10.1530/ERC-11-0298. Print 2012 Jun. Endocr Relat Cancer. 2012. PMID: 22383427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page